Edwards Lifesciences Corp is 39.1x more valuable than Enovis CORP by market capitalization ($49.51 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENOV | EW |
|---|---|---|
| Market cap | $1.26 B | $49.51 B |
| US-listed rank | #2460 | #320 |
| Revenue (latest FY) | $2.25B | $6.07B |
| Net income (latest FY) | -$1.18B | $1.07B |
| Net margin | -52.7% | 17.7% |
| P/E (trailing FY) | - | 46.1 |
| SEC filings | 1,645 | 2,569 |
Edwards Lifesciences Corp is 39.1x more valuable than Enovis CORP by market capitalization ($49.51 B vs $1.26 B).
In their latest fiscal years, Enovis CORP reported $2.25B in revenue while Edwards Lifesciences Corp reported $6.07B.
Full pages: Enovis CORP and Edwards Lifesciences Corp, or browse the full rankings.